• About
  • Privacy Policy
  • Contact
Saturday, June 14, 2025
No Result
View All Result
NEWSLETTER
Diplomatic Info
  • Home
  • Diplomacy
  • Embassy News and Info
  • Events
  • Nigeria
  • Business
  • Politics
  • Security
  • Cover Story
  • ECOWAS
    • Togo
    • Sierra Leone
    • Senegal
    • Nigeria
    • Niger
    • Mali
    • Liberia
    • Guinea Bissau
    • Guinea
    • Ghana
    • The Gambia
    • Cote D’Ivoire
    • Cabo Verde
    • Burkina Faso
    • Benin
  • Advertise
    • mail
  • Home
  • Diplomacy
  • Embassy News and Info
  • Events
  • Nigeria
  • Business
  • Politics
  • Security
  • Cover Story
  • ECOWAS
    • Togo
    • Sierra Leone
    • Senegal
    • Nigeria
    • Niger
    • Mali
    • Liberia
    • Guinea Bissau
    • Guinea
    • Ghana
    • The Gambia
    • Cote D’Ivoire
    • Cabo Verde
    • Burkina Faso
    • Benin
  • Advertise
    • mail
No Result
View All Result
Diplomatic Info
No Result
View All Result
Home International

German vaccine developer, CureVac forms partnership with Bayer

by diplomaticinfo
January 7, 2021
in International
0
German vaccine developer, CureVac forms partnership with Bayer
0
SHARES
6
VIEWS
Facebook ShareShare on WhatsAppTweet it!

Berlin, Jan. 7, 2020 – Pharmaceutical giant Bayer has joined forces with German firm CureVac to develop and supply a potential COVID-19 vaccine, the companies said.

CureVac, headquartered in the south-western city of Tuebingen, has long been working on its own vaccine.

Thursday’s announcement makes it the latest small German vaccine developer to team up with a market heavyweight, following on from BioNTech and U.S. company Pfizer, whose vaccine is already being administered in numerous countries following regulatory approvals.

Under the collaboration and services agreement, Germany’s Bayer will support CureVac in conducting clinical testing and establishing supply-chain infrastructure, statements from the companies said.

CureVac began phase 3 of its clinical testing on the experimental vaccine CVnCoV in mid-December, embarking on a key step towards regulatory approval.

The first results of these studies are expected in the first quarter of this year.

The European Commission has tentatively ordered 405 million doses of the CureVac drug.

CureVac chief executive Franz-Werner Haas said his company now has “another strong partner” on its side.

Under the agreement, CureVac would still be the marketing authorisation holder for the product if approved, while Bayer could be the holder in other markets outside of Europe.

Armin Laschet, premier of Bayer’s home state of North Rhine Westphalia and a possible contender to lead Merkel’s party in September elections, welcomed the partnership on Twitter.

“Another ray of light on the horizon. It’s good to have strong pharmaceutical companies in the country,” he wrote.

CureVac has more than 500 employees, according to its own count.

Almost a quarter of the company (23 per cent) belongs to Germany’s state development bank KfW, following a 300-million-euro (368-million-dollar) investment in June 2020.

The government stake was intended to prevent a foreign takeover of the company. (dpa/NAN)

diplomaticinfo

diplomaticinfo

Next Post
Democrats takeover of U.S. Senate prompts share-buying in Japan and Oz

Democrats takeover of U.S. Senate prompts share-buying in Japan and Oz

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Recommended

EFCC secures arrest warrant against fleeing ex-Gov Yahaya Bello

N80.2 Billion Fraud: Kogi Assembly asks EFCC to remove Yahaya Bello’s name from wanted list

1 year ago
Torture is ‘awful subject’ that media shuns, says doctor on UN body

Torture is ‘awful subject’ that media shuns, says doctor on UN body

3 years ago

Popular News

  • Israeli president says situation ‘very serious’ amid judicial overhaul debate

    Israeli president says situation ‘very serious’ amid judicial overhaul debate

    0 shares
    Share 0 Tweet 0
  • Communal clash: Osun Govt. imposes 24 hour curfew on 2 LGAs

    0 shares
    Share 0 Tweet 0
  • APC chairman Adamu commends INEC on BVAS, optimistic on Tinubu’s victory

    0 shares
    Share 0 Tweet 0
  • Senate set to screen Service Chiefs this week, says Ndume

    0 shares
    Share 0 Tweet 0
  • Buhari arrives Washington for U.S.-Africa leaders summit

    0 shares
    Share 0 Tweet 0

Connect with us on Facebook

Subscribe to Our Newsletter

Enter your email now to join our community of readers, and get new contents straight to your inbox

We promise to not spam you

Thanks for joining in.

Category

  • Africa
  • Benin
  • Burkina Faso
  • Business
  • Cote D'Ivoire
  • Cover Story
  • Diplomacy
  • ECOWAS
  • Education
  • Embassy News and Info
  • Events
  • Ghana
  • Guinea
  • Guinea Bissau
  • International
  • Liberia
  • Mali
  • News
  • Niger
  • Nigeria
  • Politics
  • Programs
  • Security
  • Senegal
  • Sierra Leone
  • The Gambia
  • Togo
  • Uncategorized

Quick Links

  • About
  • Contact
  • Privacy Policy
  • Advertise

About Us

Providing strategic insights into important social, cultural, political, and economic factors that significantly influence business and nations, Diplomatic Info will examine these critical issues and provide strategies that create competitive advantages.

© 2023 Diplomatic Info - Built with Love by Creovantage.

No Result
View All Result
  • Home
  • Diplomacy
  • Embassy News and Info
  • Events
  • Business
  • Politics
  • Security
  • News
  • Cover Story
  • Africa
  • ECOWAS
    • Togo
    • Sierra Leone
    • Senegal
    • Nigeria
    • Niger
    • Mali
    • Liberia
    • Guinea Bissau
    • Guinea
    • The Gambia
    • Cote D’Ivoire
    • Ghana
    • Cabo Verde
    • Benin
    • Burkina Faso
  • International
  • Contact

© 2023 Diplomatic Info - Built with Love by Creovantage.